Hideyoshi Harashima Selected Research

Hideyoshi Harashima Research Topics

Disease

99	Neoplasms (Cancer) 05/2024 - 10/2005
17	Mitochondrial Diseases (Mitochondrial Disease) 04/2023 - 02/2007
9	Neoplasm Metastasis (Metastasis) 03/2024 - 09/2013
9	Renal Cell Carcinoma (Grawitz Tumor) 05/2022 - 01/2012
7	Bites and Stings (Sting) 03/2024 - 06/2014
7	Melanoma (Melanoma, Malignant) 03/2024 - 03/2011
7	Urinary Bladder Neoplasms (Bladder Cancer) 12/2018 - 03/2009
6	Body Weight (Weight, Body) 10/2021 - 08/2011
5	COVID-19 05/2024 - 10/2021
5	Fibrosis (Cirrhosis) 02/2024 - 03/2021
5	Type 2 Diabetes Mellitus (MODY) 03/2014 - 12/2003
4	Obesity 10/2021 - 03/2013
4	Infections 01/2021 - 01/2013
3	Brain Diseases (Brain Disorder) 01/2018 - 04/2014
3	Insulin Resistance 03/2016 - 06/2015
3	Carcinogenesis 06/2011 - 12/2006
2	Congenital Heart Defects (Congenital Heart Defect) 02/2024 - 07/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2021
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2023 - 10/2021
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2023
2	Communicable Diseases (Infectious Diseases) 01/2023 - 01/2022
2	Glaucoma 11/2022 - 03/2021
2	Cardiomyopathies (Cardiomyopathy) 01/2020 - 10/2018
2	Colitis 12/2018 - 07/2016
2	Lymphoma (Lymphomas) 03/2016 - 02/2015
2	Reperfusion Injury 12/2015 - 09/2015
2	Hypersensitivity (Allergy) 06/2011 - 05/2011
2	Tuberculosis (Tuberculoses) 06/2011 - 05/2011
2	Carcinoma (Carcinomatosis) 06/2011 - 03/2009

Drug/Important Bio-Agent (IBA)

39	Small Interfering RNA (siRNA)IBA 12/2023 - 05/2009
24	Liposomes (Liposome)IBA 01/2022 - 10/2005
22	Lipid NanoparticlesIBA 05/2024 - 06/2011
20	LipidsIBA 01/2023 - 10/2007
18	LigandsIBA 01/2022 - 11/2011
15	Peptides (Polypeptides)IBA 01/2019 - 10/2005
12	Messenger RNA (mRNA)IBA 05/2024 - 12/2003
12	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2003
10	Proteins (Proteins, Gene)FDA Link 04/2015 - 12/2006
9	AntigensIBA 05/2024 - 05/2011
9	Mitochondrial DNA (mtDNA)IBA 04/2023 - 10/2008
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 09/2007
7	InterferonsIBA 03/2024 - 06/2014
6	Therapeutic UsesIBA 03/2024 - 06/2011
6	Nucleic AcidsIBA 01/2022 - 01/2010
5	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2010
5	Matrix Metalloproteinases (MMPs)IBA 12/2016 - 05/2007
5	Tuberculin (PPD)IBA 06/2011 - 10/2007
4	Photosensitizing Agents (Photosensitizers)IBA 01/2023 - 01/2020
4	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2020 - 05/2009
4	octaarginineIBA 11/2019 - 03/2009
4	Hyaluronic Acid (Hyaluronan)IBA 10/2019 - 06/2015
4	CytokinesIBA 11/2017 - 05/2011
4	Insulin (Novolin)FDA Link 03/2016 - 12/2006
4	YSK05IBA 10/2015 - 06/2013
3	mRNA VaccinesIBA 05/2024 - 01/2023
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 01/2020
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 12/2016
3	Vitamin E FDA LinkGeneric 01/2020 - 02/2015
3	Cell-Penetrating PeptidesIBA 01/2017 - 08/2012
3	bis(3',5')-cyclic diguanylic acidIBA 12/2016 - 06/2014
3	Blood Glucose (Blood Sugar)IBA 01/2016 - 03/2014
3	Interferon Type IIBA 10/2015 - 06/2014
3	Nucleotide AptamersIBA 08/2014 - 01/2012
3	Cell Wall SkeletonIBA 02/2014 - 06/2011
3	liposomal doxorubicin (Doxil)FDA Link 07/2013 - 02/2007
2	OligodeoxyribonucleotidesIBA 03/2024 - 03/2011
2	AntioxidantsIBA 10/2023 - 01/2020
2	Oxygen (Dioxygen)IBA 01/2023 - 10/2021
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 06/2014
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022 - 10/2018
2	VaccinesIBA 01/2022 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2021 - 09/2015
2	MidkineIBA 10/2021 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 10/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2020
2	PorphyrinsIBA 01/2020 - 01/2020
2	OvalbuminIBA 12/2018 - 01/2017
2	Dextran SulfateIBA 12/2018 - 07/2016
2	Myristic Acid (Tetradecanoic Acid)IBA 12/2018 - 02/2015
2	Nanoparticle Drug Delivery SystemIBA 11/2017 - 12/2016
2	coenzyme Q10 (CoQ10)IBA 01/2017 - 09/2015
2	cyclic arginine-glycine-aspartic acid peptideIBA 01/2016 - 09/2015
2	Triglycerides (Triacylglycerol)IBA 01/2016 - 03/2014
2	Glucose (Dextrose)FDA LinkGeneric 06/2015 - 09/2013
2	Biomarkers (Surrogate Marker)IBA 08/2014 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 02/2007
2	LeptinIBA 10/2013 - 03/2013

Therapy/Procedure

50	Therapeutics 03/2024 - 10/2005
26	Immunotherapy 05/2024 - 03/2009
5	Photochemotherapy (Photodynamic Therapy) 01/2023 - 08/2008
5	Transplantation 01/2022 - 09/2013
4	Intravenous Administration 01/2023 - 10/2007
3	Cell Transplantation 02/2024 - 01/2020
3	Drug Therapy (Chemotherapy) 02/2015 - 01/2014
2	Precision Medicine 01/2024 - 04/2016
2	Intravenous Injections 12/2023 - 01/2023
2	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2023 - 11/2021
2	Injections 01/2022 - 01/2014
2	Lab-On-A-Chip Devices 10/2021 - 01/2017
2	Lasers (Laser) 01/2017 - 03/2009